By performing in silico analyses, we showed that the promotor sequence of the human ACTBL2 gene—enconding κ-actin, a novel member of the actin family that was originally detected in hepatoma cells (Chang et al., 2006)—contains several putative NFAT5 binding sites (Figure 2A). Here, NFAT5 is linked to hepatocellular carcinoma.